Chemomab Earns New Patents for CM-101, Pioneering Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases.
Share this post
Biotech Company Secures New Patent For…
Share this post
Chemomab Earns New Patents for CM-101, Pioneering Monoclonal Antibody in Clinical Development for Fibro-Inflammatory Diseases.